In the past week, UPC stock has gone up by 17.61%, with a monthly gain of 16.29% and a quarterly plunge of -80.17%. The volatility ratio for the week is 38.30%, and the volatility levels for the last 30 days are 30.86% for Universe Pharmaceuticals INC The simple moving average for the past 20 days is 9.64% for UPC’s stock, with a -99.27% simple moving average for the past 200 days.
Is It Worth Investing in Universe Pharmaceuticals INC (NASDAQ: UPC) Right Now?
UPC has 36-month beta value of 1.54.
The public float for UPC is 0.21M, and currently, short sellers hold a 8.49% ratio of that float. The average trading volume of UPC on April 22, 2025 was 372.45K shares.
UPC) stock’s latest price update
Universe Pharmaceuticals INC (NASDAQ: UPC)’s stock price has increased by 16.29 compared to its previous closing price of 3.56. However, the company has seen a 17.61% increase in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-20 that Jiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of 40 ordinary shares with par value of US$0.28125 per share each in the Company’s issued and unissued share capital into one (1) ordinary share with par value of US$11.25 (the “Share Consolidation”). As a result of the Share Consolidation, each 40 pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders.
UPC Trading at -14.36% from the 50-Day Moving Average
After a stumble in the market that brought UPC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.84% of loss for the given period.
Volatility was left at 30.86%, however, over the last 30 days, the volatility rate increased by 38.30%, as shares surge +17.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -35.71% lower at present.
During the last 5 trading sessions, UPC rose by +17.61%, which changed the moving average for the period of 200-days by -99.76% in comparison to the 20-day moving average, which settled at $3.78. In addition, Universe Pharmaceuticals INC saw -83.03% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for UPC
Current profitability levels for the company are sitting at:
- -0.11 for the present operating margin
- 0.32 for the gross margin
The net margin for Universe Pharmaceuticals INC stands at -0.19. The total capital return value is set at -0.09. Equity return is now at value -50.22, with -30.97 for asset returns.
Based on Universe Pharmaceuticals INC (UPC), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at 0.2. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -22.49.
Currently, EBITDA for the company is -3.22 million with net debt to EBITDA at -0.06. When we switch over and look at the enterprise to sales, we see a ratio of 0.03. The receivables turnover for the company is 3.01for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
To put it simply, Universe Pharmaceuticals INC (UPC) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
